Examkin

Soru

Zorluk: OrtaPulmonary and Critical Care

A 62-year-old man is evaluated in the intensive care unit on day 6 of mechanical ventilation. He was initially intubated for acute respiratory distress syndrome (ARDS) secondary to severe influenza A pneumonia. Over the past 48 hours, he has developed worsening hypoxemia, increased purulent endotracheal secretions, and a new fever of 38.8°C (101.8°F). His medical history includes moderate chronic obstructive pulmonary disease (COPD) and heart failure with preserved ejection fraction.

Current ventilator settings in volume-control mode are:
Fraction of inspired oxygen (FiO2): 0.60
Positive end-expiratory pressure (PEEP): 14 cm H2O
Tidal volume: 6 mL/kg of predicted body weight
Respiratory rate: 24/min

Arterial blood gas analysis shows:
pH: 7.28
pCO2: 54 mm Hg
pO2: 68 mm Hg
HCO3-: 24 mEq/L

A chest radiograph reveals a new focal consolidation in the right lower lobe, superimposed on bilateral diffuse alveolar opacities. Two days ago, when the fever began, he was empirically started on intravenous vancomycin and cefepime. Today, the bronchoalveolar lavage quantitative culture grows Streptococcus pneumoniae that is susceptible to ceftriaxone, levofloxacin, and linezolid.

Which of the following are appropriate interventions for this patient's ongoing management? (Select all that apply)

  1. De-escalate antibiotic therapy to intravenous ceftriaxoneCevap
  2. Maintain the current tidal volume strategy and tolerate the mild respiratory acidosisCevap
  3. C
    Continue the current broad-spectrum antibiotic regimen with vancomycin and cefepime
  4. D
    Increase the tidal volume to 10 mL/kg of predicted body weight to normalize the arterial pH
  5. E
    Administer intravenous furosemide and manage the hypoxemia primarily as acute decompensated heart failure

Cevap

De-escalate antibiotic therapy to intravenous ceftriaxone AND maintain the current tidal volume strategy while tolerating the mild respiratory acidosis.
This patient has developed ventilator-associated pneumonia (VAP) superimposed on ARDS. Because the bronchoalveolar lavage culture isolated Streptococcus pneumoniae susceptible to ceftriaxone, the most appropriate step is to de-escalate from empiric broad-spectrum therapy (vancomycin and cefepime) to targeted, narrow-spectrum therapy (ceftriaxone). This promotes antibiotic stewardship. Additionally, the patient is on a lung-protective ventilation strategy (tidal volume of 6 mL/kg) for ARDS. This strategy often results in permissive hypercapnia (elevated pCO2 and mild respiratory acidosis). Since the pH remains in a safe range (> 7.15-7.20), this acid-base derangement should be tolerated to avoid ventilator-induced lung injury.

Adım Adım Çözüm

1
Identify the new clinical complication.
The patient has developed ventilator-associated pneumonia (VAP) caused by Streptococcus pneumoniae, evidenced by fever, purulent secretions, new consolidation, and a positive culture.
Accurate diagnosis of the new decompensation is essential for appropriate targeted management.
2
Determine the appropriate antibiotic strategy based on culture results.
The pathogen is susceptible to ceftriaxone. Empiric broad-spectrum therapy should be narrowed.
Antibiotic stewardship requires transitioning to the most targeted, effective therapy available to minimize resistance and side effects.
3
Evaluate the current ventilator settings and acid-base status in the context of ARDS.
The patient is receiving lung-protective ventilation (6 mL/kg tidal volume) and has a mild, expected respiratory acidosis (pH 7.28).
In ARDS, low tidal volumes prevent lung injury. The resulting hypercapnia and acidemia (permissive hypercapnia) are tolerated as long as the pH remains above 7.15 to 7.20.

Anahtar Kavram

Integration of antibiotic stewardship in ventilator-associated pneumonia and maintenance of permissive hypercapnia during lung-protective ventilation for ARDS.
Bu soruyu puanla

Konular

Pulmonary and Critical Care

Bu konudan daha fazla soru